1-2 of 2
Hiroki Ozawa
Close
Sort by
Journal Articles

Hypoxic adaptation of leukemic cells infiltrating the CNS affords a therapeutic strategy targeting VEGFA

Itaru Kato, Yoko Nishinaka, Masahiro Nakamura, Ayse U. Akarca, Akira Niwa, Hiroki Ozawa, Kenichi Yoshida, Makiko Mori, Dapeng Wang, Makiko Morita, Hiroo Ueno, Yusuke Shiozawa, Yuichi Shiraishi, Satoru Miyano, Rajeev Gupta, Katsutsugu Umeda, Kenichiro Watanabe, Katsuyoshi Koh, Souichi Adachi, Toshio Heike, Megumu K. Saito, Masashi Sanada, Seishi Ogawa, Teresa Marafioti, Akira Watanabe, Tatsutoshi Nakahata, Tariq Enver
Journal: Blood
Blood (2017) 129 (23): 3126–3129.
https://doi.org/10.1182/blood-2016-06-721712
Published: 2017
Includes: Supplemental data
Journal Articles

VEGFA- a New Therapeutic Target in CNS Leukemia

Itaru Kato, MD, PhD, Yoko Nishinaka-Arai, PhD, Masahiro Nakamura, MD PhD, Ayse U. Akarca, BSc, Akira Niwa, MD, PhD, Hiroki Ozawa, Kenichi Yoshida, MD PhD, Makiko Mori, MD, Dapeng Wang, PhD, Hiroo Ueno, MD, Yusuke Shiozawa, MD, Yuichi Shiraishi, PhD, Satoru Miyano, PhD, Rajeev Gupta, MD, PhD, Katsutsugu Umeda, MD PhD, Kenichiro Watanabe, MD PhD, Katsuyoshi Koh, MD PhD, Souichi Adachi, MD, PhD, Toshio Heike, MDPhD, Megumu K Saito, MD, PhD, Masashi Sanada, MD PhD, Seishi Ogawa, MD PhD, Teresa Marafioti, MD, Akira Watanabe, PhD, Tatsutoshi Nakahata, MD PhD, Tariq Enver, PhD
Journal: Blood
Blood (2016) 128 (22): 911.
https://doi.org/10.1182/blood.V128.22.911.911
Published: 2016